A phase II study to evaluate INP-104 for migraine.
Latest Information Update: 22 Sep 2022
At a glance
- Drugs Dihydroergotamine mesilate (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 25 Jan 2017 New trial record
Latest Information Update: 22 Sep 2022